This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
EV-302
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher® Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
mCRPC with Bone Metastasis
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Urologic Catheters (Includes CAUTI)
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Actionable Clinical Data
Bladder Cancer
LG-IR NMIBC
Adstiladrin®
Kidney Cancer
ZIRCON
Trials in Progress
Trials in Progress
Bladder Cancer
BOND-003 Cohort P
CORE-008
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
UCLA-UCSF-PCF PSMA 2025
EAU 2025
SES AUA 2025
Thought Leaders 2025
APCCC Diagnostics 2025
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Bladder Cancer
Conferences
Recent Abstracts
AUA 2017: The Impact of Scribes on Urology Practice
May 19, 2017
AUA 2017: E-Cigarette Smoke is potentially Bladder Carcinogenic- It Induces Tumorigenic DNA Adducts and Inhibits DNA Repair in Urothelial Cells
May 18, 2017
AUA 2017: Best Abstract – Focal therapy of prostate cancer: Defining appropriate treatment margins using MRI: whole mount co-registration
May 18, 2017
AUA 2017: Best Abstract - Novel in vitro Organoid Technology to Facilitate a Precision Medicine Approach in the Management of Men with Biochemical Recurrence of Prostate Cancer
May 18, 2017
AUA 2017: Best Abstract – The current management of prostate cancer in the United States: Data from the AQUA registry
May 18, 2017
AUA 2017: askMUSIC: Leveraging a Clinical Registry to Inform Patients
May 18, 2017
AUA 2017: Radical Prostatectomy Versus Observation for Early Prostate Cancer: Follow-Up Results of the Prostate Cancer Intervention Versus Observation Trial (PIVOT)
May 18, 2017
AUA 2017: State-of-the-Art Lecture: Circulating Tumor Cells
May 18, 2017
AUA 2017: Racial Disparities and Genetic Variabilities in Prostate Cancer
May 18, 2017
AUA 2017: State-of-the-Art Lecture: Immunotherapy for Bladder Cancer
May 18, 2017
AUA 2017: Highlights of Urologic Oncology Research
May 18, 2017
AUA 2017: Modified 5-item frailty index is associated with increased healthcare resource utilization following elective minimally invasive radical nephrectomy
May 18, 2017
AUA 2017: Can partial nephrectomy provide equal oncological efficiency and safety compared with radical nephrectomy in patients with renal cell carcinoma (≥ 4 cm)? A propensity score matched study
May 18, 2017
AUA 2017: Influence of Statin Intake on PSA Values, Risk of Prostate Cancer Development and Survival in a Prospective Screening Trial Cohort (ERSPC)
May 18, 2017
AUA 2017: Multiparametric MRI represents an added value but not a substitute of follow-up biopsies in patients on active surveillance for low-risk prostate cancer
May 18, 2017
AUA 2017: 11C-Choline versus 68ga-PSMA PET/CT scan for the detection of nodal recurrence from prostate cancer: results from a large, multi-institutional salvage lymph node dissection series
May 18, 2017
AUA 2017: Elderly Prostate Cancer Patients Have A Worse Prognosis Than Younger Patients: A Population-based Study In The Netherlands
May 18, 2017
AUA 2017: Statin Use, Serum Lipid Levels and Prostate Inflammation; Results from the Reduce Study
May 17, 2017
AUA 2017: Fasting Blood Glucose and Prostate Cancer Risk in the Finnish Randomized Study of Screening for Prostate Cancer
May 17, 2017
AUA 2017: Plenary Next Frontier
May 17, 2017
Page 492 of 614
Start
Prev
487
488
489
490
491
492
493
494
495
496
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free